gefitinib has been researched along with beta-solamarine in 1 studies
Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (beta-solamarine) | Trials (beta-solamarine) | Recent Studies (post-2010) (beta-solamarine) |
---|---|---|---|---|---|
5,231 | 566 | 2,919 | 63 | 2 | 38 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Han, L; Li, J; Tang, Q; Wang, R; Wang, S; Wang, X; Wu, W; Xu, M; Yang, X; Zhou, Q | 1 |
1 other study(ies) available for gefitinib and beta-solamarine
Article | Year |
---|---|
Solamargine enhanced gefitinib antitumor effect via regulating MALAT1/miR-141-3p/Sp1/IGFBP1 signaling pathway in non-small cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Drug Resistance, Neoplasm; ErbB Receptors; Gefitinib; Gene Expression Regulation, Neoplastic; Humans; Insulin-Like Growth Factor Binding Protein 1; Lung Neoplasms; MicroRNAs; Protein Kinase Inhibitors; RNA, Long Noncoding; Signal Transduction | 2023 |